Eculizumab Improves Posttransplant Thrombotic Microangiopathy Due to Antiphospholipid Syndrome Recurrence but Fails to Prevent Chronic Vascular Changes
Open Access
- 13 June 2013
- journal article
- case report
- Published by Elsevier BV in American Journal of Transplantation
- Vol. 13 (8), 2179-2185
- https://doi.org/10.1111/ajt.12319
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Eculizumab for Atypical Hemolytic Uremic Syndrome Recurrence in Renal TransplantationAmerican Journal of Transplantation, 2012
- Eculizumab in Severe Shiga-Toxin–Associated HUSNew England Journal of Medicine, 2011
- Renal Thrombotic Microangiopathy in Mice with Combined Deletion of Endocytic Recycling Regulators EHD3 and EHD4PLOS ONE, 2011
- Severe Vascular Lesions and Poor Functional Outcome in Kidney Transplant Recipients with Lupus Anticoagulant AntibodiesAmerican Journal of Transplantation, 2010
- The Use of Antibody to Complement Protein C5 for Salvage Treatment of Severe Antibody-Mediated RejectionAmerican Journal of Transplantation, 2009
- The Role of Antiphospholipid Syndrome in Cardiovascular DiseaseHematology/Oncology Clinics of North America, 2008
- Banff 07 Classification of Renal Allograft Pathology: Updates and Future DirectionsAmerican Journal of Transplantation, 2008
- Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: Prevalence, clinical associations, and long‐term outcomeArthritis & Rheumatism, 2004
- Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal HemoglobinuriaNew England Journal of Medicine, 2004
- The Antiphospholipid SyndromeNew England Journal of Medicine, 2002